Low MOQ supplement manufacturing for brands at any stage
Most supplement brands need their first production run before they have demand data, not after. A brand launching a new SKU on Amazon, a practitioner developing a clinic line, or a founder testing a formula in a new category — all need a manufacturing partner willing to run a small batch at production-grade quality, with third-party testing, compliant labeling, and the same rigor applied to a 5,000-unit run that a large operator receives on a 500,000-unit contract.
Sun Nutraceuticals manufactures two-piece capsules and stand-up pouch powders starting at 5,000 units. That is the same production floor for a brand's first SKU as for an established brand adding a new product. Every run — regardless of volume — produces finished goods with a Certificate of Analysis from a third-party accredited laboratory, a batch record traceable to the master formula, and packaging configured for the channels you are actually selling through: Amazon FBA, DTC, or B2B retail.
Low MOQ supplement manufacturing is not a concession Sun makes for small brands. It is how we run the facility. The same production lines, the same formulation team, the same testing protocols apply at 5,000 units as at 500,000. What changes with volume is pricing per unit and production scheduling priority, not quality or compliance rigor.
What 5,000 units actually gets you
A 5,000-unit production run at Sun produces a commercially viable batch in compliant packaging with documentation sufficient for regulatory review, retail listing, and marketplace compliance audits. The specifics vary by format, but the outputs are consistent across runs of any size.
Capsule production
Two-piece capsules filled on production-grade automated filling equipment. Gelatin, HPMC, or pullulan shells in sizes 00 through 1. Fill weights from 300 mg to 1,000 mg per capsule depending on ingredient density. Bottles labeled, capped, and lot-coded. A 5,000-unit run produces approximately 50–100 cases depending on the bottle count configuration you select.
Powder production
Blended and filled into stand-up resealable pouches from 100 g to 1 kg. Flavored and unflavored. Lot-coded and sealed on production equipment. At 5,000 units, you receive labeled, finished pouches ready for immediate sale — no additional packaging steps before shipping to your 3PL or directly to Amazon FBA inbound.
Third-party testing
Every batch — including 5,000-unit first runs — goes through a third-party accredited laboratory before release. Testing covers active ingredient identity confirmation, potency analysis, and a microbial safety panel. The Certificate of Analysis provided with each batch is the document Amazon, retailers, and B2B buyers request. It is production-standard documentation, not a pre-production estimate.
Labeling and regulatory compliance
Finished product labels follow 21 CFR Part 101 dietary supplement labeling requirements — Supplement Facts panel, net weight, ingredient declaration, structure/function claims where applicable, and required disclaimer language. We review label artwork before production and flag any claim that requires adjustment before it goes to print.
Batch records
Every production run generates a complete batch record — the documentation chain linking raw material COAs to finished product test results. For brands subject to retailer or marketplace compliance audits, the batch record resolves most inquiries. It also serves as the production baseline for all future runs of the same formula, with no reformulation required on repeat orders.
Integrated fulfillment
Finished goods can transfer directly from production into Sun's integrated fulfillment operation for case labeling, Amazon FBA prep, or DTC pick-and-pack — without leaving the facility. For first-batch brands without warehouse infrastructure, this removes a significant logistics step between finished production and the first customer shipment.
Low MOQ manufacturing specifications
| Capsule MOQ | 5,000 units |
|---|---|
| Powder MOQ | 5,000 units |
| Capsule shells | Gelatin (bovine), HPMC (vegetarian), pullulan (vegan) |
| Capsule sizes | 00, 00el, 0, 1 — size 2 on request |
| Capsule fill weight range | 300 mg – 1,000 mg per capsule (density-dependent) |
| Powder pouch sizes | 100 g, 250 g, 500 g, 1 kg stand-up resealable pouches |
| Production lead time | 6–10 weeks from formula approval and component arrival |
| Custom formulation development | 4–6 weeks (simple); 8–12 weeks (multi-ingredient) |
| Testing | Third-party COA on every batch — identity, potency, microbials |
| Certifications | FDA-registered facility, cGMP compliant |
| Fulfillment | Amazon FBA prep, DTC pick-and-pack, B2B pallet — available from first batch |
Custom formulation versus near-stock formula at low MOQ
Brands entering low MOQ manufacturing typically arrive at one of two starting points: they have a formula they want produced, or they need one developed. Both paths produce finished goods at 5,000 units, but the timeline and upfront cost differ meaningfully.
Custom formulation at low MOQ adds a development phase before production. A brief is finalized, ingredient candidates are bench-tested, a formula is locked, and a master formula record is created. Development fees apply and are credited against the first production run. Total timeline from project start to finished goods: typically 10–18 weeks depending on formula complexity. The output is a formula the brand owns, documented to a standard that supports future scale runs, audits, and eventual transfer to a secondary manufacturer if needed. For a first-to-market stack, a proprietary dose ratio, or a category where formula differentiation is the brand story, custom development at 5,000 units is the correct starting point even if it requires more upfront investment.
Near-stock formulas at low MOQ use ingredient combinations and dose ranges within established production parameters — creatine monohydrate capsules, collagen peptide powders, BCAA blends, and similar standard-category formulations. These move faster because raw material procurement and production parameters are already established. For brands whose differentiation comes from brand strategy, channel execution, or marketing rather than formula IP, a near-stock formula at low MOQ is a faster and lower-cost path to first inventory.
Many brands use a custom formula for their hero SKU and a near-stock formula for supporting SKUs. That combination is efficient — the brand differentiates on the product that matters commercially and fills out the catalog without excess development cost on formulas where category-standard ingredients are acceptable.
The small batch production process
- Quote and scoping. You describe your product concept — format, ingredient direction, MOQ, timeline, and intended channel. We provide a production quote and initial timeline within one business day. For custom formulation projects, the quote covers both development and first-run production in a single figure.
- Formula finalization. If you have a formula, we review and confirm it against our production parameters. If you need formulation development, bench work begins from your approved brief. Either way, the formula is documented in a master formula record before production begins — the source document for every batch that follows.
- Component procurement. Raw materials and packaging components are sourced from qualified suppliers with existing COAs on file. For standard categories — creatine, collagen, BCAA, botanical leaf powders, and adaptogens — we hold established supplier relationships. Specialty or novel ingredients may require additional lead time for qualification before procurement.
- Production. Blending, filling, capping, labeling, and case-packing run on Sun's production lines under documented SOPs and quality-control checkpoints. Batch records are generated at each stage and tied to the lot number on your finished product.
- Third-party testing. Finished goods are submitted to an accredited third-party laboratory for identity, potency, and microbial analysis. Product does not release until a passing Certificate of Analysis is received, reviewed, and attached to the batch record. No exceptions for small-batch runs.
- Delivery or fulfillment. Finished goods ship to your warehouse, or transfer directly into Sun's integrated fulfillment operation for Amazon FBA prep, DTC pick-and-pack, or B2B palletized outbound. Finished goods typically ship the same week production and testing clear.
Who low MOQ supplement manufacturing is for
Low MOQ production at 5,000 units serves a specific set of supplement brands well. The situations below describe the most common entry points for brands working with Sun on small-batch programs.
- Founders launching a first SKU. A brand with no revenue history cannot responsibly commit to a 50,000-unit run — the demand signal does not exist yet. A 5,000-unit batch validates the product in market, generates real-world sales data, and provides the information needed to size the second run accurately. The production infrastructure — testing, batch records, labeling — is identical to what an established brand uses. The unit count is smaller; the compliance standard is not.
- Amazon sellers entering the supplement category. On Amazon, the first ASIN for a supplement brand is a test. Reviews have not accumulated, conversion rate is unknown, and the right price point may need validation. A 5,000-unit run provides enough inventory to run an initial listing, gather data, and build order velocity before committing to the volume that earns better per-unit pricing. FBA prep is available without leaving the production facility.
- Established brands testing a new formula or category. A brand with existing high-volume production on proven SKUs sometimes needs to test adjacent products — a new ingredient, a different format, or a sub-brand concept — without committing the production capacity reserved for proven lines. A separate 5,000-unit test batch for the new SKU sits alongside the existing program and produces real-market data before a scale commitment.
- Practitioners and clinicians building supplement lines. Healthcare practitioners who want formulations specific to their clinical protocols — capsules dosed to their patient population, or powders designed for their therapeutic approach — often need small-batch manufacturing that does not require a commercial sales forecast to justify. A 5,000-unit custom capsule run produces a year's supply for an active clinic practice and gives practitioners full label control, documented potency, and a product they can recommend with a traceable COA behind it.
- Brands transitioning from stock to proprietary formulas. Private-label and white-label operators may want to introduce a proprietary formula alongside stock SKUs without requiring a large-volume first commitment. Low MOQ manufacturing gives these brands the path from stock to custom without needing to forecast significant volume on an untested formula before the first batch ships.
Small batch manufacturing: cost and timeline realities
Brands should enter low MOQ manufacturing with accurate expectations on two variables: per-unit cost and lead time. Both differ from what a high-volume operator experiences, and both are structural realities of small-batch production — not signals about quality.
Per-unit cost is higher at low MOQ. Fixed costs — third-party laboratory testing, documentation, equipment setup, and production changeover — are spread across fewer units at 5,000 than at 50,000. A 5,000-unit batch of creatine capsules costs more per unit than a 50,000-unit batch of the same formula. This cost structure is consistent across the industry. At Sun, the per-unit cost at 5,000 units is what it actually costs to produce at that quantity with full testing and documentation intact — not a discounted rate that absorbs cost somewhere else in the process.
Lead time does not compress for small batches. Third-party laboratory testing, raw material procurement from qualified suppliers, and production scheduling have minimum durations that do not meaningfully shrink at 5,000 units versus 50,000. A 5,000-unit capsule run takes the same 6–10 weeks from component arrival to finished goods as a larger run on the same formula. Planning backward from a launch date with 10–12 weeks of production buffer — plus custom formulation development time if applicable — is the standard parameter for small-batch programs.
Scaling is frictionless once the formula is locked. The master formula record from the first 5,000-unit run is the production document for every subsequent batch. Moving from a first small-batch run to a 25,000-unit repeat order does not require reformulation, re-qualification, or re-testing of the formula — only production scheduling and component procurement change. Per-unit cost decreases at higher volumes because fixed costs are spread across more units. Brands that treat their first run as a market validation step before scaling have a clear and well-documented path to lower per-unit pricing on future orders.
Frequently asked questions
What is the minimum order quantity for capsules at Sun Nutraceuticals?
The minimum order quantity for capsule production at Sun Nutraceuticals is 5,000 units. This applies to both custom-formulated and near-stock formulas in gelatin, HPMC, and pullulan shells across sizes 00 to 1.
What is the minimum order quantity for powder supplements?
The minimum order quantity for powder supplements at Sun Nutraceuticals is 5,000 units in stand-up resealable pouches ranging from 100 g to 1 kg fill. Both custom-formulated and near-stock powder blends are available at this MOQ.
Can I use a custom formula at a low MOQ?
Yes. Custom formulation development runs alongside production at Sun — you do not need a high-volume commitment to access custom formulation. First production runs for custom formulas start at 5,000 units. Development fees are quoted separately and credited against the first production run.
What is the lead time for a small batch supplement production run?
Lead time from formula approval and component arrival to finished goods is typically 6 to 10 weeks for both capsule and powder formats. Near-stock formulas can move faster if raw materials are in stock. Custom formulation adds 4 to 12 weeks of development time before production begins, depending on complexity.
Do small batch runs go through the same testing as large production runs?
Yes. Every production run at Sun Nutraceuticals — regardless of unit count — is subject to third-party laboratory testing for active ingredient identity, potency confirmation, and microbial safety. Certificates of Analysis are provided with every batch. Testing protocols do not vary by batch size.
Can I scale up after my first small batch run?
Yes. The master formula record from your first run is the production document for all subsequent batches. Scaling from a 5,000-unit first batch to 50,000 or more units on repeat orders follows the same protocol with no re-development or re-qualification required. Per-unit cost decreases as volume increases.
Is a low MOQ supplement manufacturer the right fit for an Amazon launch?
For brands launching on Amazon, a 5,000-unit first run provides enough inventory to list an initial ASIN, validate reviews and conversion rate, and build order history before committing to a higher-volume run. Sun's integrated fulfillment service handles Amazon FBA prep — case labeling, poly-bagging, case-pack configuration — so finished goods ship Amazon-ready.
What capsule shell types are available at the 5,000-unit MOQ?
Gelatin (bovine), HPMC (vegetarian), and pullulan (vegan) shells are all available at the standard 5,000-unit MOQ. Capsule sizes 00, 00el, 0, and 1 are in regular production rotation. Size 2 is available on request. Shell type selection does not affect the minimum order requirement.